← back to search

Marsha Rich Rosner

University of Chicago · US
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include Melanoma and MAPK Pathways, Cancer Mechanisms and Therapy, Protein Kinase Regulation and GTPase Signaling, and RNA modifications and cancer.
h-index
66
citations
14,210
works
309
NIH funding
primary concept
email

Recent publications

Nonmonotone invasion landscape by noise-aware control of metastasis activator levels
Nature Chemical Biology 2023cited by 19position: middledoi
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
Science Advances 2022cited by 137position: lastdoi
SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells
mBio 2022cited by 29position: middledoi
Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop
Proceedings of the National Academy of Sciences 2022cited by 16position: lastdoi
New strategies for targeting kinase networks in cancer
Journal of Biological Chemistry 2021cited by 55position: lastdoi
Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
Cancers 2021cited by 42position: lastdoi
Limited inhibition of multiple nodes in a driver network blocks metastasis
eLife 2021cited by 34position: lastdoi
Observation and Control of Gene Expression Noise: Barrier Crossing Analogies Between Drug Resistance and Metastasis
Frontiers in Genetics 2020cited by 25position: middledoi
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
Nature 2019cited by 411position: lastdoi
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
The Journal of Experimental Medicine 2019cited by 115position: middledoi
Targeting Raf Kinase Inhibitory Protein Regulation and Function
Cancers 2018cited by 51position: lastdoi
Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome
Proceedings of the National Academy of Sciences 2017cited by 48position: lastdoi
Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages
Cancer Research 2015cited by 129position: lastdoi
Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions
Proceedings of the National Academy of Sciences 2014cited by 148position: lastdoi
Raf Kinase Inhibitory Protein (RKIP) as a Metastasis Suppressor: Regulation of Signaling Networks in Cancer
Critical Reviews™ in Oncogenesis 2014cited by 72position: lastdoi
RKIP Structure Drives Its Function: A Three-State Model for Regulation of RKIP
Critical Reviews™ in Oncogenesis 2014cited by 30position: lastdoi
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
Proceedings of the National Academy of Sciences 2013cited by 290position: lastdoi
Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells
RNA 2013cited by 156position: middledoi
RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2
Oncogene 2013cited by 101position: lastdoi
RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin Therapy
PLoS ONE 2013cited by 61position: middledoi
A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients
PLoS ONE 2013cited by 54position: lastdoi
An integrated view of cyclin E function and regulation
Cell Cycle 2012cited by 174position: middledoi
Nonheritable Cellular Variability Accelerates the Evolutionary Processes of Cancer
PLoS Biology 2012cited by 64position: lastdoi
Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
PLoS ONE 2012cited by 63position: middledoi
Identification of novel metastasis suppressor signaling pathways for breast cancer
Cell Cycle 2012cited by 25position: lastdoi

Grants

International Conference on Structure and Functions of Biomembranes, November 1989, Calcutta, India, Award in Indian Currency
NSF8914545$27,2001989–1990PIRePORTER

Frequent collaborators

Casey Frankenberger · Rush University Medical Center7 papers (2013–2021)Ali E. Yesilkanal · Bristol-Myers Squibb (Germany)5 papers (2014–2021)Jiyoung Lee · George Washington University5 papers (2014–2022)Devipriya Sankarasharma · Columbia University3 papers (2013–2015)Payal Tiwari · Broad Institute3 papers (2019–2021)Gábor Balázsi · Roswell Park Comprehensive Cancer Center3 papers (2014–2023)Long C. Nguyen · Massachusetts General Hospital3 papers (2021–2023)Kiran Chada · Columbia University3 papers (2013–2015)Elena Bevilacqua · Azienda Sanitaria Universitaria Integrata di Trieste3 papers (2012–2014)Dongbo Yang · University of Chicago3 papers (2020–2022)Daniel C. Rabe · Tempus Labs (United States)3 papers (2015–2021)Suzana Gomes · University of Chicago3 papers (2013–2022)Jieun Yun · Pohang University of Science and Technology3 papers (2012–2014)Andrea Valdespino · The Wistar Institute2 papers (2021–2022)Gary L. Johnson · University of North Carolina at Chapel Hill2 papers (2021–2021) · 2 papers (2012–2013)Kevin S. Farquhar · The University of Texas Health Science Center at Houston2 papers (2014–2023)Lev Becker · MEI Pharma (United States)2 papers (2015–2019)John J. Skinner · University of Pennsylvania2 papers (2014–2017) · 2 papers (2021–2021)